Skip to content

Strength for Health

Safety and Efficacy of Home-based Resistance Training in Colorectal Cancer Survivors

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01882972
Enrollment
0
Registered
2013-06-21
Start date
2013-06-30
Completion date
2013-09-30
Last updated
2015-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer

Brief summary

Despite a robust literature on the benefits of exercise for cancer survivors, most of the research to date falls in two primary areas - aerobic exercise and breast cancer survivors. The focus on aerobic training alone is a concern as resistance training is critical for building the muscle mass necessary to maintain physical function. However, concerns have been raised about the potential for higher than tolerated adverse event rates during resistance training, particularly that which is unsupervised, despite a history of safe use of resistance training in other chronically diseased patient populations. The aim of this pilot study is to demonstrate the feasibility, safety and quality of life benefit of a home-based resistance-training program among colorectal cancer survivors. The investigators will recruit n=30 men and women with stage I-III colon cancer. Participants will be randomized to a home-based exercise intervention that combines aerobic and resistance exercise. Control arm participants will receive a home-based meditation program.

Detailed description

The investigators will recruit n=30 patients with stage I-III colorectal cancer and randomize them to a 12-week resistance training intervention with Theraband and existing evidence- based materials or attention control using a meditation intervention. Using an electronic survey tool, patients will complete a baseline questionnaire on key outcomes (quality of life, fatigue, side effects) and potential confounders and will consent to a medical record review. These will also be assessed via at 4 weeks post randomization and 12 weeks post randomization. Participants in the intervention group will receive one-time in person instruction in the exercises derived from the existing evidence base of home-based resistance training programs for older adults and cancer survivors. They will be sent home with a book demonstrating the exercises, a log and a set of appropriate resistance bands. Weekly follow-up calls will occur for the duration of the intervention and updates on the call results will be provided to the colon cancer clinic nurse so that care is integrated. Participants in the attention control group will be mailed a meditation CD. Follow-up in the control group will parallel that of the intervention group, with weekly calls.

Interventions

BEHAVIORALExercise
BEHAVIORALMeditation

Sponsors

Hygenic Corporation
CollaboratorUNKNOWN
Loyola University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* stage I-III colorectal cancer * completed surgical treatment * at least 12 weeks post-surgery. * at least 4 weeks post adjuvant therapy. * age 18 and older.

Exclusion criteria

* patients who had surgery more than 24 months ago. * patients with related pre-existing conditions (i.e., Crohn's disease, ulcerative colitis, familial polyposis syndromes).

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of recruitment14 monthsAbility to meet the recruitment goal of 30 subjects in a 14 month period, reflecting a participation rate of at least 20% among approached and eligible patients
Retention feasibility14 monthsRetention of at least 80% of randomized patients to the follow-up visit. A drop-out rate of less than 20%

Secondary

MeasureTime frameDescription
Pain12 weeksChange in participant reported pain from baseline to 12 weeks
quality of life12 weeksChange in Quality of life score as measured by the FACT-C and FACT-F from baseline to 12 weeks
Surgical Complications12 weeksDifference in rate of reported surgical complications between arms at 12 weeks
Self-reported Exercise-related Injury12 weeksdifference in self reported exercise-related injury rate between arms at 12 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026